Becton, Dickinson and Co. (NYSE:BDX)
Becton Dickinson makes all sorts of medical devices and instruments, including scalpels, syringes, and diagnostic equipment.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Recs
Free Cash Flow and ROE, wow!
Recs
Steady dividend in a growth industry.
Recs
242. Becton Dickinson (NYSE: BDX) looks cheap to me. Target: $80-$85. I'm betting CAPS points on this one. This qualifies as a no brainer as far as I can tell. They've been consistent in the past and their present price does not reflect that combined with a growth profile heading forward. This is a hardcore buy if you can get it below $70, meaning that you should consider it as a core position in your portfolio to trade around. The dividend is admirable but it won't attract the high yield investing subclass that seems to be growing as the babyboomers retire.
http://beta.fool.com/bradford86/2012/01/09/price-market-part-35/
Recs
Just bought this in my IRA (72.75). Seems way over sold on a risk/reward basis if you ask me.
Recs
12/30/11
Trading at 11.7 times 2013 earnings, BDX is pretty cheap. I'm going to predict they trade up 20% to $89 in the next 12 months from the currently level of $75. Projected 10% earnings growth for 2013 is modest, but they should receive a higher PEG for achieving steady 9-12% earnings growth for several years to come. I love that have also increased the dividend consistently over the past 28 years. They currently yield 2.40% and pay out $1.80 per year. This stock makes a great core holding to any portfolio.
Recs
Recs
Bought BDX both as short-term defensive & long-term growth prospect. The upside/downside ratio is favorable at current levels. Company is well positoned to grow in emerging markets, but must adjust product costs to truly compete. I'm betting on BDX management to figure it al out and resume their historic consistant growth.
Recs
I've been following BDX for awhile. It popped up in an article screen with an attractive valuation.
http://www.fool.com/investing/value/2011/11/29/investing-with-shock-absorbers.aspx
Stable business - medical stuff, much of it disposable meaning demand is always there.
Long history of dividend hikes.
Decent yield
Low volatility
Disclosure - no position, but this fits the profile of the kind of stock I like to own.
Recs
4* dividend aristocrat, will outperform more speculative names during the coming market downturn....
Recs
There will be already is competition in this field that will undercut the margin this outfit requires
Recs
Pretty cheap and they just announced a dividend increase of 10%. They can afford it too. They have 3.87 times more cash flow than needed to cover the current dividend payment.
Recs
sequoia purchase
Recs
Another extremely strong company that hasn't recovered from the August selloff. Fair value based on weighted average of P/E, P/B, P/S, ROE, ROA is $80.00
Recs
This is a "Giant Tortoise Stock." Like a giant tortoise, It may be big and slow, but it has a hard shell (economic moat), can swim far (enter into new and emerging markets and industries), and live long.
Recs
This is not about beating the market, at least in the short term. UNP is one of the few great companies as to which one can set up a TOTALLY FREE direct investment/drip plan. The plan is available at www.computershare.com.
I initiated with a very small $300 investment (the minimum), and a $50 monthly auto-withdraw from my bank account that will start next month. I'm tagging this because today the first $300 was withdrawn from my bank account. There are zero fees for my investment purchases, and zero fees for reeinvestment of dividends. That's not to say I'll just buy any company because there are no fees involved. But I have no problem including this company in my little portfolio.
I'm not so concerned about a huge margin of safety here, because the amounts are small, and this is just intended to be a twenty-year drip. Note you'd ideally want dividend stocks like this a tax-free IRA. I buy like this because I already otherwise max out my yearly 401k and IRA contributions.
From a shorter-term pespective, this stock is well off after kissing $90 earlier this year, though I do NOT actually think this stock is vastly undervalued at this time from a FCF basis.
Recs
Look at the numbers and you will realize it is almost a CAN"T Miss
Recs
Looks awfully cheap.
Maybe hold this one for a spiffy pop.
Recs
just bought this IRL and on CAPS. this is way too low. earnings reports misses are the best.
Recs
It's currently trading for around 12 times earnings. But it's easily worth more than 20 times earnings, which would put its true value up around $108 per share. So you're buying one of the world's greatest businesses for a 40% discount to my minimum estimate of its value.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 174 : 1 2 3 4 5 6 7 8 9 Next »